Generation Bio Co.
NASDAQ:GBIO
2.16 (USD) • At close November 4, 2024
Overzicht | Financiële gegevens
Bedrijfsnaam | Generation Bio Co. |
Symbool | GBIO |
Munteenheid | USD |
Prijs | 2.16 |
Beurswaarde | 144,160,992 |
Dividendpercentage | 0% |
52-weken bereik | 1.02 - 4.65 |
Industrie | Biotechnology |
Sector | Healthcare |
CEO | Dr. Cameron Geoffrey McDonough M.D. |
Website | https://generationbio.com |
An error occurred while fetching data.
Over Generation Bio Co.
Generation Bio Co., a genetic medicines company, develops therapies for the treatment of rare and prevalent diseases. The company provides a portfolio of programs, including programs for rare and prevalent diseases of the liver and retina. It also focuses on the diseases of skeletal muscle, central nervous system, and oncology.
Vergelijkbare Aandelen
Financiële Gegevens
Cijfers zijn in miljoenen (USD)
Cijfers zijn in miljoenen (USD)